Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Contineum Therapeutics (CTNM) Interest Expenses (2023)

Contineum Therapeutics' Interest Expenses history spans 1 years, with the latest figure at $116000.0 for Q2 2023.

  • Quarterly Interest Expenses changed N/A to $116000.0 in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $116000.0 through Mar 2024, changed N/A year-over-year, with the annual reading at $208000.0 for FY2023, N/A changed from the prior year.
  • Interest Expenses came in at $116000.0 for Q2 2023, up from $92000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $116000.0 in Q2 2023 to a low of $92000.0 in Q1 2023.